发明名称 |
Medical use of sPLA2 hydrolysable liposomes |
摘要 |
<p>The present invention relates to medical use of liposomes, more particular the first medical use of sPLA2 hydrolysable liposomes. Such liposomes may be used for targeted delivery of therapeutic agents to cancerous tissue and in such embodiments; the therapeutic agents are typically small molecule antitumor agents. Other aspects of the inventions relates to methods of reducing the side effects of therapeutic agents, e.g. reducing nephrotoxicity, neurotoxicity and gastrointestinal toxicity of a therapeutic agent. Yet another aspect of the present invention relate to methods of prolonging the therapeutic effect of a therapeutic agent.</p> |
申请公布号 |
AU2010294971(B2) |
申请公布日期 |
2015.08.20 |
申请号 |
AU20100294971 |
申请日期 |
2010.09.16 |
申请人 |
BIO-BEDST APS |
发明人 |
PETERSEN, MORTEN JUST;MELANDER, FREDRIK;VIKBJERG, ANDERS FALK;PETERSEN, SUNE ALLAN;MADSEN, MOGENS WINKEL |
分类号 |
A61K9/127;A61K31/282;A61K33/24;A61P35/00 |
主分类号 |
A61K9/127 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|